Consistent with our results are the outcomes of immunohistochemical analysis of GBM that showed significantly lower expression of PTEN (p < 0.05) in tumor tissue compared to the surrounding healthy brain tissue [46]. This evidence concerns the gene PTEN and glioblastoma.